Olema Pharmaceuticals, Inc.
OLMA
$27.53
$0.381.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.22M | -43.78M | -30.39M | -33.57M | -34.56M |
| Total Depreciation and Amortization | 43.00K | 132.00K | 128.00K | 116.00K | 95.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.23M | 3.27M | 2.56M | 4.99M | 3.91M |
| Change in Net Operating Assets | 4.42M | 10.50M | -16.28M | 2.18M | 3.53M |
| Cash from Operations | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.27M | 34.23M | -45.08M | -114.42M | 45.92M |
| Cash from Investing | 17.27M | 34.23M | -45.08M | -114.42M | 45.92M |
| Total Debt Issued | 0.00 | 3.00M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 41.00K | 982.00K | 236.00K | 250.80M | 92.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -6.50M | -14.00K | -6.50M | 0.00 |
| Cash from Financing | 41.00K | -2.52M | 222.00K | 244.30M | 92.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.21M | 1.83M | -88.84M | 103.59M | 19.00M |